Compara mètodes

	EORTC QLQ-BR23: Qualitat de vida en càncer de mama	FACT-Lung: Avaluació Funcional de la Teràpia contra el Càncer
Camp	Oncologia	Oncologia
Família	Process / pipeline	Process / pipeline
Any d'origen	1996	1995
Autor original	Sprangers, M. A., et al. (EORTC Quality of Life Group)	David F. Cella, Ph.D.
Tipus	Self-report questionnaire	Self-report questionnaire
Font seminal	Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768.	Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Validation of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument for patients with lung cancer. J Clin Oncol, 13(1), 142–153.
Àlies	QLQ-BR23	FACT-L
Relacionats	5	5
Resum	The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.	The FACT-Lung (FACT-L) is a lung-cancer-specific quality-of-life measure that combines a 27-item general cancer assessment with a 7-item lung cancer subscale. Developed by Cella et al. in 1995, it quantifies physical, emotional, social, and functional well-being specifically relevant to lung cancer patients. It is widely used in clinical trials and practice to assess treatment impact and symptom burden.